Genelabs Receives $1.25 Million from Affymetrix and AtheroGenics to Present at JPMorgan Healthcare Conference.
Publication: M2 Presswire
Publication Date: 30-DEC-04
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
M2 PRESSWIRE-30 December 2004-FNWU: Genelabs Receives $1.25 Million from Affymetrix and AtheroGenics to Present at JPMorgan Healthcare Conference(C)1994-2004 M2 COMMUNICATIONS LTD
RDATE:12302004
City of Industry, CA - Biotechnology industry news provided by Financial News USA (OTC: FNWU). Genelabs Technologies, Inc. (Nasdaq: GNLB) announced today that it received $1.25 million...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
